{"id":63271,"date":"2022-03-25T05:06:12","date_gmt":"2022-03-25T05:06:12","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=88887"},"modified":"2022-03-25T05:06:12","modified_gmt":"2022-03-25T05:06:12","slug":"informa-pharma-intelligence-launches-30th-edition-pharma-rd-annual-review","status":"publish","type":"post","link":"https:\/\/indonesiatribune.com\/informa-pharma-intelligence-launches-30th-edition-pharma-rd-annual-review\/","title":{"rendered":"Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review"},"content":{"rendered":"
NEW YORK, March 24, 2022 (GLOBE NEWSWIRE) — Informa Pharma Intelligence<\/a>, the global business intelligence provider for the biopharma industry, today announced the launch of its 30<\/a>th<\/sup><\/a> Edition Pharma R&D Annual Review<\/a>. The 2022 report assesses industry trends by examining the pharmaceutical pipeline by company, therapeutic area, disease, target, and drug type, using data from Pharma Intelligence\u2019s Pharmaprojects, part of the Citeline suite of products, which has been tracking global drug development since 1980.<\/p>\n The 55-page free report features a travel theme and includes a full analysis and breakdown of 2021 and what to expect for the year ahead. Notable findings include:<\/p>\n For the past 30 years, Ian Lloyd, Senior Director, Pharmaprojects & Data Integration, has authored this must-have industry report for those seeking to identify the changing fortunes of drug R&D. To celebrate this milestone, Lloyd has shared five key insights from past R&D reviews that have come to fruition or are still trending today.<\/p>\n For more information, or to view the current and past reports, visit Informa Pharma Intelligence<\/a> or contact pharma@informa.com<\/a>.<\/p>\n About Informa Pharma Intelligence<\/strong> With more than 400 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn\u2019t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com<\/a><\/p>\n\n
\n
\nInforma Pharma Intelligence powers a full suite of analysis products \u2014 Datamonitor Healthcare\u2122, Sitetrove\u2122, Trialtrove\u2122, Pharmaprojects\u2122, Biomedtracker\u2122, Scrip\u2122, Pink Sheet\u2122 and In Vivo\u2122 \u2014 to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.<\/p>\n